About the Partners

The pan-Canadian Cancer Drug Funding Sustainability Initiative is led by CAPCA, working together with the cancer programs, CADTH/ pCODR, INESSS and pCPA

  • Canadian Agency for Drugs and Technologies in Health /pan-Canadian Oncology Drug Review (CADTH/pCODR): An independent, not for profit organization, funded by Canada’s federal, provincial, and territorial governments, except Quebec. The pan-Canadian Oncology Drug Review (pCODR) is a CADTH program responsible for providing oncology drug reimbursement recommendations to participating federal, provincial, and territorial cancer organizations.
  • Canadian Partnership Against Cancer (CPAC): An independent organization funded by the federal government to accelerate action on cancer control for all Canadians.
  • Institut national d’excellence en santé et services sociaux (INESSS): In Quebec, INESSS promotes clinical excellence and the efficient use of resources in the health and social services sector. It assesses clinical advantages and costs of technologies, medications and interventions used in health care and personal social services, and provides recommendations to the Minister of Health concerning adoption, use and funding, including development of clinical practice guidelines to ensure optimal use.
  • pan-Canadian Pharmaceutical Alliance (pCPA): All 13 provinces and territories and the federally funded drug plans participate in pCPA. The goal is to work together to achieve greater value for brand name and generic drugs for publicly funded drug programs.